RxDoctor Payments DataLook up a doctor →

Robert Guirguis, DO

Pain Medicine · Tampa, FLNPI 1134170038

Payments from drug & device makers

$894,993in general payments, 2019–2025

Across 1,126 payments — averaging $794.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seikagaku Corporation$864K
  • Medtronic$7K
  • Boston Scientific$2K
  • Scilex Pharmaceuticals Inc.$2K
  • Abbott$2K
  • AbbVie$2K
  • plus $15K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seikagaku Corporation27$864,281
Medtronic(2 entities)161$7,270
Boston Scientific80$2,305
Scilex Pharmaceuticals Inc.51$2,126
Abbott62$2,099
AbbVie(2 entities)99$1,988
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC122$1,650
Curonix LLC36$1,614
Collegium Pharmaceutical, Inc.106$1,523
Relievant Medsystems, Inc.9$1,205
Nevro Corp.29$1,062
Pfizer50$826
Tersera Therapeutics LLC29$657
Globus Medical11$630
Idorsia Pharmaceuticals US Inc24$598
Biohaven Pharmaceutical Holding Company Ltd.17$493
Eisai Inc.28$378
Azurity Pharmaceuticals, Inc.17$339
Stimwave Technologies Incorporated4$313
SPR Therapeutics, Inc10$273
Redhill Biopharma Inc.13$267
Electronic Waveform Lab, Inc.8$266
Biohaven Pharmaceuticals, Inc.16$258
Lilly USA, LLC13$206
Biodelivery Sciences International, Inc.7$205
Arbor Pharmaceuticals, Inc.10$190
Zynex Medical, Inc.1$180
Amgen(2 entities)7$166
AstraZeneca10$153
Teva Pharmaceuticals USA, Inc.9$127
E.r. Squibb & Sons, L.L.C.1$121
Novartis5$111
Stryker1$104
Forte Bio-pharma LLC5$94
Nalu Medical, Inc.4$83
IBSA Pharma Inc.4$74
Biotronik NRO, Inc.2$72
MDD US Operations, LLC5$68
Takeda Pharmaceuticals U.S.A., Inc.6$58
Kaleo, Inc.4$54
Flowonix Medical Incorporated2$50
Saluda Medical Americas, Inc.1$45
Protega Pharmaceutials Inc1$41
Assertio Therapeutics, Inc.2$40
Shionogi Inc2$39
Pacira Pharmaceuticals Incorporated2$39
Biogen3$39
GRT US Holding, Inc.2$34
Si-bone, Inc.1$33
Corelink, LLC1$30
Vertos Medical, Inc.1$26
Daiichi Sankyo Inc.1$23
Hikma Pharmaceuticals USA1$21
USWM, LLC1$19
Fidia Pharma USA Inc.1$14
Valinor Pharma, LLC1$14

How this compares

$894,993 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$170,683
Medicare patients
254
Services billed
1,781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →